SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133551
Filing Date
2022-04-29
Accepted
2022-04-29 16:04:45
Documents
4
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d517665ddef14a.htm DEF 14A 443445
2 GRAPHIC g517665g00a02.jpg GRAPHIC 70811
3 GRAPHIC g517665g11a15.jpg GRAPHIC 243089
4 GRAPHIC g517665g22c15.jpg GRAPHIC 231186
  Complete submission text file 0001193125-22-133551.txt   1195572
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38800 | Film No.: 22875141
SIC: 2836 Biological Products, (No Diagnostic Substances)